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The Terminal Oxidase Cytochrome 
bd Promotes Sulfide-resistant 
Bacterial Respiration and Growth
Elena Forte1,*, Vitaliy B. Borisov2,*, Micol Falabella1, Henrique G. Colaço3, Mariana Tinajero-
Trejo4, Robert K. Poole5, João B. Vicente6, Paolo Sarti1 & Alessandro Giuffrè7
Hydrogen sulfide (H2S) impairs mitochondrial respiration by potently inhibiting the heme-copper 
cytochrome c oxidase. Since many prokaryotes, including Escherichia (E.) coli, generate H2S and 
encounter high H2S levels particularly in the human gut, herein we tested whether bacteria can sustain 
sulfide-resistant O2-dependent respiration. E. coli has three respiratory oxidases, the cyanide-sensitive 
heme-copper bo3 enzyme and two bd oxidases much less sensitive to cyanide. Working on the isolated 
enzymes, we found that, whereas the bo3 oxidase is inhibited by sulfide with half-maximal inhibitory 
concentration IC50 = 1.1 ± 0.1 μM, under identical experimental conditions both bd oxidases are 
insensitive to sulfide up to 58 μM. In E. coli respiratory mutants, both O2-consumption and aerobic 
growth proved to be severely impaired by sulfide when respiration was sustained by the bo3 oxidase 
alone, but unaffected by ≤200 μM sulfide when either bd enzyme acted as the only terminal oxidase. 
Accordingly, wild-type E. coli showed sulfide-insensitive respiration and growth under conditions 
favouring the expression of bd oxidases. In all tested conditions, cyanide mimicked the functional 
effect of sulfide on bacterial respiration. We conclude that bd oxidases promote sulfide-resistant O2-
consumption and growth in E. coli and possibly other bacteria. The impact of this discovery is discussed.
Along with nitric oxide (NO) and carbon monoxide (CO), hydrogen sulfide (H2S) has been recognized as an 
important gaseous signalling molecule, playing a major role in human (patho)physiology1. Like NO and CO, H2S 
is a key regulator of many physiological processes in the cardiovascular, nervous, respiratory and gastrointestinal 
systems, among others. While exerting beneficial physiological effects at lower levels, at higher concentrations 
H2S can cause detrimental effects. In eukaryotes, depending on its concentration, H2S can have opposite effects on 
respiration (reviewed in2): at nanomolar concentrations it can sustain energy metabolism both as a substrate for 
the mitochondrial respiratory chain and as a vasodilator favouring O2 supply, whereas at higher levels it impairs 
cellular respiration via direct binding to and inhibition of mitochondrial cytochrome c oxidase (mtCcOX) (see3 
and references therein). Sulfide inhibition of mtCcOX is very effective (Ki = 0.2–0.45 μM at pH = 7.43,4), leading 
to dissipation of the mitochondrial membrane potential, consequent arrest of aerobic ATP production and even-
tually cell death2.
In mammalian tissues, H2S is enzymatically produced by cystathionine β -synthase (CBS), cystathionine 
γ -lyase (CSE) and via the combined action of 3-mercaptopyruvate sulfurtransferase (3-MST) and cysteine ami-
notransferase (reviewed in5). At variance from other compartments in the human body, in the intestinal lumen 
H2S is also generated by the gut microbiota through bacterial amino acid metabolism and via dissimilatory sulfate 
reduction by ‘sulfate-reducing bacteria’ (SRB)6. H2S levels in the gut are therefore high. Whereas the total sulfide 
pool content in the colon is around one millimolar7, the concentration of free H2S in the intestinal lumen was 
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reported to be ca. 40–60 μM, as estimated by direct measurement of the gas in the rat cecum8,9 and analysis of 
human faecal samples10.
E. coli is a ubiquitous member of the human gut microbiota, with more than one strain commonly colonizing 
the large intestine at the same time. Since E. coli, like the other microorganisms inhabiting the gut, lives in a par-
ticularly H2S-enriched microaerobic niche, the question arises as to whether this microorganism can accomplish 
O2-dependent respiration without being inhibited by H2S. The E. coli respiratory chain possesses three terminal 
oxygen reductases, utilizing quinols as reducing substrates: the cyanide-sensitive cytochrome bo3 enzyme and 
the bd-I and bd-II oxidases, much less sensitive to cyanide11,12. Cytochrome bo3 belongs to the superfamily of 
heme–copper oxygen reductases that includes mtCcOX. The enzyme contains three redox-active metal centres: 
the low-spin heme b involved in quinol oxidation and a binuclear site composed of heme o3 and CuB, where O2 
reduction to water takes place. On the contrary, bd-I and bd-II are cytochrome bd-type O2-reductases phyloge-
netically unrelated to heme–copper oxidases12. They have no copper, but contain three hemes: the low-spin heme 
b558 (the primary electron acceptor from the quinol), and the two high-spin hemes b595 and d (possibly forming 
a di-heme site for O2 reduction, see12 and references therein). Cytochrome bo3 predominates in E. coli under 
high aeration, whereas O2-limiting conditions such as those found in the human gut stimulate the expression of 
the cytochromes bd-I and bd-II13–15. The three E. coli terminal oxidases all generate a proton motive force, but 
cytochrome bo3 is the only one able to pump protons, thus being twice as effective as bd-type cytochromes in 
terms of energy transduction16. Besides its role in bacterial energy metabolism, cytochrome bd-I was suggested 
to serve other physiological functions, being implicated in the bacterial response to oxidative and nitrosative 
stress17–20.
In this work, we examined the effect of sulfide on the O2 reductase activity of the three terminal oxidases of 
E. coli and tested the ability of these enzymes to sustain bacterial growth and O2 consumption in the presence of 
sulfide.
Results
Effect of NaHS on isolated E. coli terminal oxidases. The effect of sulfide on the O2 reductase activity 
of the E. coli respiratory oxidases, cytochromes bo3, bd-I and bd-II, was initially investigated testing the ability 
of each purified oxidase to consume O2 before and after addition of the sulfide donor NaHS. In these assays, 
O2 consumption was measured in the presence of dithiothreitol (DTT) and 2,3-dimethoxy-5-methyl-6-(3- 
methyl-2-butenyl)-1,4-benzoquinone (Q1) as the reducing system. As shown in Fig. 1A, NaHS (~7 μM) rapidly 
and effectively inhibits the O2 reductase activity of the isolated cytochrome bo3. The enzyme is inhibited with 
an apparent half-maximal inhibitory concentration IC50 = 1.1 ± 0.1 μM (Fig. 2). The inhibition of cytochrome 
bo3 is fully reversible. A rapid and complete recovery of the O2 reductase activity of the isolated enzyme was 
observed, when sulfide was quickly removed from solution by addition of an excess of O-acetyl-L-serine (OAS) 
and catalytic amounts of the sulfide-consuming O-acetylserine sulfhydrylase enzyme from Entamoeba histolytica 
(EhOASS, Fig. 1A). Sulfide consumption by EhOASS in the presence of OAS was assessed independently using 
a H2S-selective electrode (Figure S1). Notably, while being an effective inhibitor of E. coli cytochrome bo3, NaHS 
proved to be unable to inhibit the two E. coli bd-type oxidases. Addition of NaHS, even at high concentration 
(58 μM), did not alter the O2 consumption catalyzed by the bd-I or bd-II enzyme in the presence of DTT and Q1 
(Fig. 1A). No O2 consumption stimulation by the OAS/EhOASS sulfide-scavenging system was observed in con-
trol oxygraphic experiments carried out in the absence or presence of the isolated oxidases (not shown).
Effect of NaHS on E. coli respiration. The striking results obtained with the isolated enzymes prompted 
us to explore the effect of sulfide on E. coli cell respiration. To this end, we investigated aerobic cultures of E. coli 
(see Methods for details) and tested the effect of NaHS on cell respiration along cell growth, i.e., at increasing cell 
density. We initially assayed three mutant strains each expressing a single terminal oxidase (bo3, bd-I or bd-II). 
The results were remarkably similar to those obtained with the isolated enzymes. O2 consumption by E. coli cells 
expressing solely cytochrome bo3 was quickly and fully inhibited upon addition of 50 μM NaHS (Fig. 1B). As 
observed with the isolated bo3 enzyme, the inhibition was promptly and fully restored upon sulfide depletion by 
the EhOASS/OAS system (Fig. 1B). In contrast, no inhibition was observed following the addition of 50 μM NaHS 
to E. coli cells expressing either bd-I or bd-II as the only terminal oxidase (Fig. 1B). The results on the three mutant 
strains proved to be independent of the density at which cells were collected and assayed (Fig. 3, top panel). 
Similarly to NaHS, cyanide (50 μM) almost completely abolished O2-consumption in E. coli cells expressing only 
the bo3 oxidase, whereas it was essentially ineffective when respiration was sustained by either bd oxidase (Fig. 3, 
bottom panel).
The effect of NaHS on respiration of the wild-type strain was assessed in the same way. Namely, we investi-
gated aerobic cultures in which a change in oxidase expression from cytochrome bo3 to the cytochromes of the 
bd-type is expected to take place along cell growth, following a progressive reduction in O2 availability in the 
medium21,22. Accordingly, when cells were assayed in an early phase of the culture (OD600 < 0.7), most of respi-
ration (65–70%) proved to be sensitive to NaHS or cyanide (both at 50 μM, Fig. 3). In contrast, with cell growth 
bacterial O2-consumption became progressively less sensitive to sulfide inhibition and, in a late phase of the cul-
ture (OD600 > 2.5), NaHS or cyanide caused only marginal effects on respiration (Fig. 3).
Altogether these results show that, unlike the heme-copper bo3 oxidase, E. coli bd oxidases enable 
O2-dependent respiration in the presence of sulfide.
Effect of NaHS on E. coli cell growth. The lack of sulfide inhibition of cytochromes bd-I and bd-II, as 
opposed to the high sensitivity displayed by the bo3 oxidase, prompted us to test whether the bd-type oxidases, 
besides enabling respiration, promote E. coli cell growth in the presence of sulfide. We investigated the effect of 
sulfide on the growth of both the wild-type and the three respiratory mutant strains. Following the addition of 
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200 μM NaHS, the wild-type strain showed a delayed growth (Fig. 4A), while the growth of the bo3-expressing 
strain was severely impaired (Fig. 4B). Lacking bd oxidases, the latter strain proved to be highly sensitive to 
sulfide, with 6 μM NaHS causing ~25% reduced cell growth, as evaluated at 2 hours after NaHS addition (inset 
Fig. 4B). In contrast, no or very little effect on cell growth was observed over the same time window after addition 
of 200 μM NaHS to the strains expressing either bd-I or bd-II as the only terminal oxidase (Fig. 4C,D). Altogether, 
these data show that, unlike the bo3 oxidase, the cytochromes bd-I and bd-II sustain E. coli growth in the presence 
of sulfide.
Discussion
Together with NO and CO, H2S is presently considered a highly relevant signalling molecule in human 
(patho)physiology. It has long been recognized that many prokaryotes, including the model organism E. coli and 
numerous other members of the human gut microbiota, generate H2S (see6 and references therein). Bacteria can 
accomplish H2S production by several pathways, including cysteine degradation by L-cysteine desulfhydrase, and 
dissimilatory sulfate reduction by SRB (see6 and references therein). In a recent study, it was reported that ort-
hologs of the mammalian H2S-synthesizyng enzymes CBS, CSE and 3-MST are widespread in the bacterial world 
and contribute to H2S generation, as demonstrated for several bacteria by genetic manipulation23. As an example, 
E. coli was shown to harbour an ortholog of 3-MST significantly contributing to bacterial H2S synthesis. Notably, 
in the same study H2S production was shown to enhance antibiotic resistance in all tested bacteria, thereby pro-
viding an adaptive advantage.
Figure 1. Effect of NaHS on E. coli terminal oxidases. (A) O2 reductase activity of the isolated cytochromes 
bd-I (20 nM), bd-II (2.5 nM) and bo3 (6 nM) as measured at 25 °C in the presence of DTT (10 mM) and Q1 
(0.25 mM). O2 consumption rates measured prior to NaHS addition (mean ± standard deviation, n = 3): 
1.62 ± 0.07 μM O2/s (bd-I); 0.54 ± 0.02 μM O2/s (bd-II) and 0.46 ± 0.02 μM O2/s (bo3). O2 consumption 
by cytochrome bo3 is rapidly inhibited (~85%) by 7.2 μM NaHS, to be quickly and completely restored 
upon removal of sulfide from solution following the addition of 200 μM OAS and 216 nM EhOASS. On 
the contrary, NaHS (58 μM) does not affect the oxidase activity of either cytochrome bd-I or cytochrome 
bd-II. (B) O2 consumption by cell suspensions of the mutant strains expressing cytochrome bd-I (400 μl 
cells with OD600 = 1.85), cytochrome bd-II (600 μl cells with OD600 = 1.17) or cytochrome bo3 (200 μl cells 
with OD600 = 2.45), as the only terminal oxidase. O2 consumption rates measured prior to NaHS addition 
(mean ± standard deviation, n = 3): 0.20 ± 0.07 μM O2/s (bd-I); 0.18 ± 0.02 μM O2/s (bd-II) and 0.19 ± 0.02 μM 
O2/s (bo3). When sustained solely by cytochrome bo3, cell respiration is rapidly inhibited by 50 μM NaHS, to be 
quickly and completely restored following sulfide removal on addition of OAS (200 μM) and EhOASS (216 nM). 
No inhibition is observed following the addition of NaHS (50 μM), when respiration is sustained by the only 
cytochrome bd-I or bd-II.
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The presence of numerous H2S-producing bacteria in the human gut makes this compartment particularly 
enriched in H2S compared to other tissues, with the free gas reaching in the intestinal lumen concentrations as 
high as 40–60 μM8–10. Relevant to human (patho)physiology, bacteria-derived H2S is emerging as a key regulator 
of several physiological functions not only in the gastrointestinal system, but also throughout the human body1. 
Moreover, it has been recently suggested that the differential susceptibility of mutualistic microbes to sulfide tox-
icity may contribute to shape the human gut microbiota6, a recognized factor contributing to human health and 
disease. In turn, the host H2S systemic bioavailability and metabolism have been found to be profoundly affected 
by the microbiota in studies on germ-free mice24. Altogether these observations provide evidence for interplay 
between H2S and the human microbiota, with important consequences on human health.
Though currently considered a key signalling molecule, H2S has long been known as a mere poison. Toxicity 
has been related to the ability of H2S to bind heme proteins and inhibit cellular respiration targeting mtCcOX 
(see3 and references therein). Indeed, H2S is a potent (Ki = 0.2–0.45 μM3,4), non-competitive inhibitor of this res-
piratory enzyme, the inhibition being reversible, independent of oxygen concentration25, but dependent on pH26. 
Sulfide inhibition of isolated mtCcOX in turnover with ascorbate and cytochrome c is relatively fast, occurring at 
an initial rate constant of 2.2 × 104 M−1 s−1, as measured at pH 7.4 3. The inhibited enzyme exhibits sulfide bound 
to ferric heme a327,28, with CuB in the cuprous state possibly bound to a second H2S molecule, as revealed by 
electron paramagnetic resonance (EPR) spectroscopy29. The mechanism of inhibition of mtCcOX is only partly 
understood, yet the reaction was suggested to involve the binding of H2S to the enzyme in turnover at cupric 
or cuprous CuB, followed by intramolecular transfer of H2S to ferric heme a3, eventually blocking the reaction 
with O23.
The well-known toxicity of H2S on mitochondrial respiration prompted us to address whether bacterial 
O2-dependent respiration can be accomplished in a H2S-enriched environment such as the human gut, thereby 
providing an adaptive advantage in terms of bacterial growth. This issue was addressed in the present study 
working on the model organism E. coli, a ubiquitous member of the human gut microbiota. Namely, we inves-
tigated the effect of sulfide on the O2 reductase activity of each of the three terminal respiratory oxidases of this 
bacterium (cytochromes bo3, bd-I and bd-II), and tested the ability of these enzymes to sustain O2 consumption 
and bacterial cell growth in the presence of sulfide. Using NaHS as a H2S donor, we carried out experiments on 
the isolated enzymes, as well as on the wild-type and three respiratory mutant E. coli strains each expressing only 
a single terminal oxidase. NaHS is commonly used as a donor of the cell permeant H2S, because in aqueous solu-
tion HS− equilibrates with H2S and S2−, according to the pKa1 ~7.0 (H2S/HS−) and pKa2 ~19 (HS−/S2−) measured 
at 25 °C. At pH = 7.0–7.4, ~30–50% of HS− is thus expected to be protonated to H2S, with S2− being present in 
negligible amounts.
As a new finding we report that, whereas the heme-copper bo3 oxidase is highly sensitive to sulfide inhi-
bition (IC50 = 1.1 ± 0.1 μM, Figs 1 and 2), the two bd oxidases (bd-I and bd-II) are remarkably insensitive to 
sulfide (Fig. 1), as confirmed by measuring the effect of NaHS on O2 consumption by the purified terminal oxi-
dases (Fig. 1A) or by whole cells (Figs 1B and 3). In agreement with these finding, cell growth proved to be 
severely impaired by sulfide in an E. coli mutant strain expressing only the bo3 oxidase (Fig. 4B), but unaffected 
in mutant strains expressing either bd-I or bd-II as the only terminal oxidase (Fig. 4, panel C,D). Consistently, in 
the wild-type strain, H2S affected cell growth and respiration only in the early phase of the culture, when O2 avail-
ability is expected to be still sufficiently high to favour the expression of the bo3 oxidase, but it caused no effect 
in a late phase of the culture, when O2 limitation is expected to stimulate the expression of bd oxidases (Fig. 4A).
Altogether, these observations led us to conclude that, at variance with the heme-copper bo3 oxidase that is 
potently and reversibly inhibited by sulfide, both E. coli bd oxidases are sulfide-insensitive and thus able to sustain 
cell respiration and growth in the presence of considerably high levels of sulfide. Although the molecular basis 
Figure 2. NaHS inhibition of isolated cytochrome bo3. Percentage inhibition of the O2 reductase activity of 
isolated cytochrome bo3 (6 nM) measured at increasing concentration of NaHS, in the presence of the 10 mM 
DTT and 0.25 mM Q1.
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for the remarkable sulfide insensitivity of the E. coli bd oxidases remains to be elucidated, it may originate from 
the lack of CuB, which was indeed suggested to be implicated in sulfide inhibition of mtCcOX3. In this regard, still 
possibly due to the lack of CuB, it is noteworthy that bd oxidases are not only more resistant to NO inhibition than 
heme-copper oxidases30–32, but also poorly sensitive to other commonly used oxidase inhibitors, such as cyanide12 
and azide33. On this basis, cyanide and sulfide are expected to exert similar inhibitory effects on E. coli respiration, 
as observed in the present study (Fig. 3).
As shown here for E. coli, it is likely that bd oxidases confer sulfide resistance also to other microorganisms. 
The bd oxidases are indeed widespread in the prokaryotic world and have been identified in numerous enterobac-
teria34, where expression of these oxidases is likely stimulated in the microaerobic conditions found in the human 
colon. In view of the novel results presented here, it will be important to test whether bd oxidases, by conferring 
sulfide resistance, play a role in shaping the human gut microbiota, thereby impacting human (patho)physiol-
ogy. Furthermore, based on these data, bd oxidases may represent very attractive targets for the development 
of next-generation antimicrobials against pathogenic enterobacteria18,20,35. Finally, the finding that bd oxidases 
enhance bacterial resistance to sulfide, if representing a hallmark of this protein family, may pave the way to bio-
technological applications aimed at increasing bacterial sulfide resistance.
Figure 3. Effect of NaHS and cyanide on respiration of E. coli cells. (Top) Residual respiratory activity 
measured after the addition of 50 μM NaHS to E. coli cells collected at the reported cell density. (Bottom) 
Comparison of the effect of cyanide and sulfide on cell respiration: respiratory activity measured after the 
addition of 50 μM NaHS or 50 μM NaCN to wild-type and mutant E. coli cells. Data (mean ± standard 
deviation) refer to the control activity measured before the addition of inhibitors (taken as 100%).
www.nature.com/scientificreports/
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Methods
Materials, bacterial strains and growth conditions. All chemicals were purchased from Sigma unless 
otherwise indicated. NaHS stock solutions were prepared by dissolving NaHS in degassed water or phosphate 
buffer saline, and the overall concentration of sulfide species (H2S/HS−/S2−) in solution was determined spectro-
photometrically according to36. All E. coli strains used were K-12 derivatives; MG1655 (RKP5416) was the wild 
type37 from which the respiratory mutants, TBE025 (MG1655 ΔcydB nuoB appB::kan), TBE026 (MG1655 ΔcydB 
nuoB cyoB::kan) and TBE037 (MG1655 ΔappB nuoB cyoB::kan) were derived, respectively expressing cytochrome 
bo3, bd-II and bd-I as the only terminal oxidase (mutants kindly given by Alex Ter Beek and Joost Teixeira de 
Mattos, University of Amsterdam). These strains carry the same mutant alleles as described by Bekker et al.38. 
E. coli cells were grown in 50 mL-Falcon tubes, in 5 mL Luria Bertani (LB) medium supplemented with 30 μg/
mL kanamycin, at 37 °C and 200 rpm. For growth studies, cells were grown as described above in the absence or 
presence of NaHS (6–200 μM) added to cells at an OD600 of about 0.05.
Purification of terminal oxidases from E. coli. The cytochromes bd-I, bd-II and bo3 were isolated from 
the E. coli strains GO105/pTK1, MB37 and GO105/pJRhisA, respectively, as previously described39–41. The con-
centration of the cytochromes bd-I and bd-II was determined from the difference absorption spectrum using 
Δε628-607 = 10.8 mM−1 cm−1 for the dithionite-reduced minus ‘as prepared’ proteins. Cytochrome bo3 concen-
tration was estimated from the Soret absorption band of the oxidized enzyme using ε 407 = 183 mM−1 cm−1. 
UV-visible absorption spectra were acquired in an Agilent Cary 60 spectrophotometer.
Purification and H2S consumption by recombinant O-acetylserine sulfhydrylase from 
Entamoeba histolytica. The O-acetylserine sulfhydrylase-encoding gene (EhOASS, Genbank 
XM_643199.1) was PCR-amplified from Entamoeba histolytica HM-1:IMSS genomic DNA using the for-
ward primer 5′-CATATGATGGAACAAATAAGTATTAGC and the reverse primer 5′-AACGTTTTA 
TTCATTCAATAATGAATCAAG, containing the NdeI and HindIII restriction sites respectively. The 
PCR product was cloned into the Topo TA pCR2.1 vector, digested with the NdeI and HindIII restriction 
enzymes, and gel purified. The DNA insert was subcloned into the NdeI and HindIII restriction sites of the 
pET28b expression vector, yielding the pET-EhOASS construct encoding N-terminally 6xHis-tagged EhOASS. 
pET-EhOASS was used to transform E. coli BL21 (DE3). Cells were grown at 37 °C in LB broth supplemented 
Figure 4. Effect of NaHS on E. coli cell growth. Cell growth of E. coli wild-type (A) and mutant strains with 
bo3 (B), bd-I (C) or bd-II (D) as the only terminal oxidase, assayed in the presence (‘closed symbols’) or absence 
(‘open symbols’) of 200 μM NaHS. Inset to panel B: Effect of NaHS on the growth of the bo3-only expressing 
mutant, as evaluated at 2 hours after addition of NaHS used at the indicated concentrations. ‘Relative OD’ 
indicates the ratio between the optical density measured at 600 nm in the presence of NaHS and the one 
recorded after the same period of time (2 hours) in the absence of NaHS. Data expressed as mean ± standard 
deviation.
www.nature.com/scientificreports/
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with 25 mg/L kanamycin (Nzytech) until OD600 reached 0.4–0.5. EhOASS expression was induced with 0.1 mM 
isopropyl-β -D-thiogalactoside addition and the cultures moved to 30 °C, 130 rpm for 4 h. Cells were harvested 
and the pellet resuspended in 10 mL/L culture of buffer A (50 mM potassium phosphate, 300 mM KCl, pH 7.5, 
10% glycerol) containing 1 mg/mL lysozyme, 1 mM phenylmethylsulfonyl fluoride and deoxyribonuclease I. After 
30-min incubation on ice, cells were disrupted by sonication, centrifuged at 8200 g (5 min, 4 °C) and imidazole 
was added to the supernatant to a final concentration of 10 mM. Protein purification steps were performed in 
an Åkta Prime (GE Healthcare) chromatography system. Affinity purification of the His-tagged protein was 
performed using a HisTrap FF crude 1-mL column previously equilibrated with buffer A containing 10 mM 
imidazole (buffer B). The cleared supernatant was loaded onto the column at 1 mL/min and the column was 
washed with 25 column volumes of buffer B followed by a linear gradient of 15 column volumes up to 500 mM 
imidazole. Pooled protein fractions were loaded onto a PD10 (GE Healthcare) desalting column for imidazole 
removal, equilibrated and washed with buffer A. EhOASS-containing fractions were concentrated with Amicon 
Ultra-15 centrifugal filter units (30 kDa cut-off) and loaded onto a size-exclusion 120-ml Superdex S-200 (GE 
Healthcare) column, equilibrated and eluted with buffer A at 0.7 mL/min. EhOASS fractions were pooled; protein 
purity was assessed by SDS-PAGE and protein concentration was determined by the Bradford assay. As previously 
reported42, pure EhOASS eluted as a dimer of ~38 kDa monomers (Figure S1).
H2S consumption by EhOASS was measured at 20 °C in 100 mM HEPES, 260 U/mL catalase, 100 μM EDTA 
pH 7.0, using an ISO-H2S-2 hydrogen sulfide sensor coupled to an Apollo 4000 Free Radical Analyzer (World 
Precision Instruments). In these assays the concentration of H2S in solution was obtained from the nominal 
concentration of the NaHS added, assuming 1:1 partition between HS- and H2S at pH 7.0, according to the pKa 
of H2S.
O2 consumption measurements. Oxygraphic measurements were carried out at 25 °C in 100 mM Na/
phosphate pH 7.4, using a high-resolution respirometer (Oxygraph-2k, Oroboros Instruments) with a 1.5 mL 
chamber. The buffer was supplemented with 0.1 mM EDTA and either 0.05% N-lauroyl-sarcosine (cytochrome 
bd-I) or 0.02% dodecyl-β -D-maltoside (cytochrome bd-II and cytochrome bo3) in the assays on isolated oxidases. 
The apparent IC50 of NaHS for the O2-reductase activity of the isolated bo3 oxidase was obtained by plotting the 
percentage inhibition of the enzyme as a function of NaHS concentration and fitting the data to the Hill equa-
tion43, assuming a Hill coefficient n = 1.
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